Company Profile

NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma
Services Division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad and San Diego, California; Research Triangle Park, North Carolina; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and Phoenix, Arizona; and CAP accredited laboratories in Cambridge, and United Kingdom. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States and Europe. 

Industry Classifications

Sector

Healthcare

Industry

Medical Diagnostics & Research

NAICS

Research and Development in Biotechnology (541711)

SIC

Testing Laboratories (8734)

Contact Information

Investor Relations

Kendra Sweeney
Investor Relations and ESG
Kendra.sweeney@neogenomics.com

Transfer Agent

Broadridge Shareholder Services
1155 Long Island Avenue
Edgewood, NY 11717-8309
T: (888) 789-8606

Company Contact

NeoGenomics, Inc.
9490 NeoGenomics Way
Fort Myers, FL 33912
T: 239-768-0600
F: 239-690-4237